|

Virtual Reality and Fear of Falling in Parkinson's Disease

RECRUITINGSponsored by Ahram Canadian University
Actively Recruiting
SponsorAhram Canadian University
Started2023-07-17
Est. completion2025-09-30
Eligibility
Age40 Years+
Healthy vol.Accepted

Summary

Background: Falls are common in elderly individuals and those with neurological conditions like Parkinson's disease. Parkinson's disease causes postural instability and mobility issues that lead to falls and reduced quality of life. The fear of falling (FoF), a natural response to unstable balance, can exacerbate postural control problems. However, evaluating FoF relies primarily on subjective self-reports due to a lack of objective assessment methods. Objectives: This mixed-methods feasibility study aims to develop an objective method for assessing fear of falling during motion and walking using virtual reality. This protocol examines a range of FoF-related responses, including cognitive, neuromuscular, and postural stability factors. Methods: Individuals without and with Parkinson's disease will complete questionnaires, movement tasks, and walking assessments in real and virtual environments where FoF can be elicited using virtual reality (VR) technology. Data from center-of-pressure measurements, electromyography, heart rate monitoring, motion capture, and usability metrics will evaluate the method's acceptability and safety. Semi-structured interviews will gather participants' and researchers' experiences of the protocol. Discussion: This method may allow accurate assessment of how FoF impacts movement by measuring cognitive, neuromuscular, and postural responses during gait and motion. Virtual environments reproduce real-life scenarios that trigger FoF. Rigorously assessing FoF with this approach could demonstrate its ability to quantify the effects of FoF on movement. Conclusions: This protocol aims to improve FoF assessment by evaluating multiple responses during movement in virtual environments. It addresses current measures' limitations. A feasibility study will identify areas for improvement specific to Parkinson's disease. Successful validation could transform how FoF is evaluated and managed.

Eligibility

Age: 40 Years+Healthy volunteers accepted
Inclusion Criteria:

* People ≥ 40 years old.
* Participants diagnosed with Parkinson's disease by a neurologist, regardless the type.
* Modified Hoehn and Yahr stages I to III.
* Able to follow instructions and understand questions.
* Able to walk independently and without walking aids.
* People who experience excessive fear of falling and fear of movement.
* Able to communicate verbally.
* Stable use of Parkinson's Disease or other comorbidities medications.

Exclusion Criteria:

* Impaired vision and hearing.
* Unstable medical condition.
* Co-existing neurological or orthopedic conditions that may limit mobility and affect participation.
* Dizziness, vertigo, headache, and motion-sickness.
* Cognition impairments.
* Pregnancy.

Conditions4

ParkinsonParkinson DiseaseParkinson's DiseaseParkinson's Disease and Parkinsonism

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.